A detailed history of Hsbc Holdings PLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Hsbc Holdings PLC holds 15,078 shares of PRTA stock, worth $211,242. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,078
Holding current value
$211,242
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$16.73 - $24.79 $252,254 - $373,783
15,078 New
15,078 $252,000
Q2 2019

Aug 13, 2019

SELL
$8.85 - $12.49 $384,408 - $542,515
-43,436 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$10.32 - $14.49 $448,259 - $629,387
43,436 New
43,436 $527,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $657M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.